Wright, A K A <br/><br/>
Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection.  [electronic resource] 

 -  Vaccine  Sep 2008 
 - 4893-903 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2008.06.058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Animals<br/>Humans<br/>Immunity, Mucosal<br/>Interleukin-12--administration & dosage<br/>Pneumococcal Infections--immunology<br/>Pneumococcal Vaccines--administration & dosage<br/>Respiratory Tract Infections--immunology